The 2026 annual meeting of the American Headache Society (AHS) is quickly approaching. From June 4 through June 7, 2026, in Orlando, Florida, the 68th Annual Scientific Meeting of the AHS is set to deliver the latest research and scientific advances to health professionals caring for patients with head, neck, and orofacial pain.

Today, we are taking some time to highlight key sessions that attendees will not want to miss. The following sessions preview features abstract presentations, topical symposia, and more. Times and dates are current as of May 4, 2026. View the official 2026 AHS annual meeting website for a complete look at the full agenda.

Upcoming Sessions at the 2026 AHS Annual Meeting

Thursday, June 4

  • Pre-Course 1: Vagus Nerve Anatomy, Physiology, Pathophysiology, and Therapeutics
    • 8:00 AM – 10:00 AM
    • Description: This session includes presentations on targeting the vagus nerve for the treatment of headache, pain, depression, seizure and cardiac conditions, integrating mindfulness and respiratory-gated vagal nerve stimulation for headache, and more.
  • Pre-Course 2: The Development and Application of Patient Reported Outcome
    • 8:00 AM – 10:00 AM
    • Description: This session includes presentations on developing patient reported outcome measures for clinical trials, incorporating patient voice when determining what to measure in migraine, and more.
  • Pre-Course 3: Refractory Headache: Diagnostic and Management Challenges Across Headache Disorders
    • 10:30 AM – 12:30 PM
    • Description: This session includes presentations on emerging therapeutics for refractory migraine, inpatient management of refractory headache, and more.
  • Pre-Course 4: Telehealth in Headache Medicine: The Clinician Will See You Now
    • 10:30 AM – 12:30 PM
    • Description: This session includes presentations on recent and ongoing original research regarding telehealth delivery models, delays in accessing care in rural and pediatric populations, and more.
  • Plenary 1: New Frontiers in Treatments
    • 2:00 PM – 3:30 PM
    • Description:  This session includes discussions on Orexin and GLP-1 research, transient receptor potential melastatin 8, and more.

Friday, June 5

  • Plenary 2: Sensitization and Placebo Keynote
    • 8:30 AM – 10:00 AM
    • Description:  This session includes discussions on intrinsic mechanisms of pain modulation, characterizing chronic overlapping pain conditioning and underlying mechanisms, and more.
  • Scientific Abstracts 1
    • 10:30 AM – 12:30 PM
    • Description: This session features research on genetic analysis of prolonged orbital severe headache, decreased cardiac autonomic regulation in individuals with migraine, and more.
  • Plenary 3: The Ear: Sound and Vestibular Sensitivity
    • 3:45 PM – 4:45 PM
    • Description: This session includes discussions on tinnitus and sound sensitivity treatment, epidemiology and treatment of vestibular migraine, and more.

Saturday, June 6

  • Scientific Abstracts 2A/2B, Concurrent
    • 10:00 AM – 11:00 AM
    • Description: These grouped sessions feature research on migraine-related photophobia, sensory hypersensitivity and quality of life impairment in migraine, headache transition care, and more.
  • Scientific Abstracts 3A/3B, Concurrent
    • 11:00 AM – 12:00 PM
    • Description: These grouped sessions feature research on electrophysiological signatures of cognitive dysfunction in chronic migraine, improvements to headache subtype classification, GLP-1 receptor agonist initiation in migraine, and more.
  • Plenary 4: Nausea and Gut-Brain Axis Disorders
    • 1:00 PM – 3:00 PM
    • Description: This session includes discussions on the pathophysiology of nausea, the gut microbiome and migraine, and more.
  • Clinical Hot Topics: Side Effects of Headache Treatments
    • 4:15 PM – 6:15 PM
    • Description: This session includes discussions on emerging side effects in Cgrp-targeted therapies, potential side effects of behavioral therapies, potential systemic effects of medications used for cluster and tacs, and more.
  • Hot Topics in Basic Science Symposium
    • 4:15 PM – 6:15 PM
    • Description: This session includes discussions on endocannabinoids, cortical astrocytes and migraine pain, galcanezumab, and more.

Sunday, June 7

  • Plenary 5: Biomarkers, Predictors, and Personalized Medicine in Headache
    • 8:30 AM – 10:00 AM
    • Description: This session includes discussions on blood biomarkers predicting treatment response in migraine, digital biomarkers of migraine, and more.

Sign up for alerts and stay informed on the latest clinical guidelines and guideline updates.